vs
Pediatrix Medical Group, Inc.（MD）与Privia Health Group, Inc.（PRVA）财务数据对比。点击上方公司名可切换其他公司
Privia Health Group, Inc.的季度营收约是Pediatrix Medical Group, Inc.的1.1倍（$541.2M vs $493.8M），Pediatrix Medical Group, Inc.净利率更高（6.8% vs 1.7%，领先5.1%），Privia Health Group, Inc.同比增速更快（17.4% vs -1.7%），过去两年Privia Health Group, Inc.的营收复合增速更高（14.2% vs -0.1%）
Pediatrix Medical Group是美国领先的专科医疗服务提供商，核心业务覆盖母胎医学、新生儿科、儿科心脏病学等儿科亚专科领域，与美国各地医疗机构合作，为女性、新生儿及儿童提供循证专科医疗服务。
Privia Health Group, Inc.是总部位于美国的医疗科技与服务企业，为独立诊所、医疗系统和医疗支付方提供价值导向型医疗解决方案，涵盖人群健康管理、患者互动平台、护理协调支持及行政流程优化工具，助力提升诊疗效果、降低医疗参与方运营成本。
MD vs PRVA — 直观对比
营收规模更大
PRVA
是对方的1.1倍
$493.8M
营收增速更快
PRVA
高出19.1%
-1.7%
净利率更高
MD
高出5.1%
1.7%
两年增速更快
PRVA
近两年复合增速
-0.1%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $493.8M | $541.2M |
| 净利润 | $33.7M | $9.2M |
| 毛利率 | — | — |
| 营业利润率 | 9.9% | 2.1% |
| 净利率 | 6.8% | 1.7% |
| 营收同比 | -1.7% | 17.4% |
| 净利润同比 | 10.5% | 108.0% |
| 每股收益（稀释后） | $0.40 | $0.08 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收MDPRVA
| Q4 25 | $493.8M | $541.2M | ||
| Q3 25 | $492.9M | $580.4M | ||
| Q2 25 | $468.8M | $521.2M | ||
| Q1 25 | $458.4M | $480.1M | ||
| Q4 24 | $502.4M | $460.9M | ||
| Q3 24 | $511.2M | $437.9M | ||
| Q2 24 | $504.3M | $422.3M | ||
| Q1 24 | $495.1M | $415.2M |
净利润MDPRVA
| Q4 25 | $33.7M | $9.2M | ||
| Q3 25 | $71.7M | $6.9M | ||
| Q2 25 | $39.3M | $2.7M | ||
| Q1 25 | $20.7M | $4.2M | ||
| Q4 24 | $30.5M | $4.4M | ||
| Q3 24 | $19.4M | $3.5M | ||
| Q2 24 | $-153.0M | $3.5M | ||
| Q1 24 | $4.0M | $3.0M |
营业利润率MDPRVA
| Q4 25 | 9.9% | 2.1% | ||
| Q3 25 | 13.8% | 2.5% | ||
| Q2 25 | 12.8% | 0.6% | ||
| Q1 25 | 7.0% | 1.1% | ||
| Q4 24 | 7.8% | 1.1% | ||
| Q3 24 | 6.6% | 1.3% | ||
| Q2 24 | -31.3% | 1.2% | ||
| Q1 24 | 3.2% | 0.2% |
净利率MDPRVA
| Q4 25 | 6.8% | 1.7% | ||
| Q3 25 | 14.5% | 1.2% | ||
| Q2 25 | 8.4% | 0.5% | ||
| Q1 25 | 4.5% | 0.9% | ||
| Q4 24 | 6.1% | 1.0% | ||
| Q3 24 | 3.8% | 0.8% | ||
| Q2 24 | -30.3% | 0.8% | ||
| Q1 24 | 0.8% | 0.7% |
每股收益（稀释后）MDPRVA
| Q4 25 | $0.40 | $0.08 | ||
| Q3 25 | $0.84 | $0.05 | ||
| Q2 25 | $0.46 | $0.02 | ||
| Q1 25 | $0.24 | $0.03 | ||
| Q4 24 | $0.37 | $0.03 | ||
| Q3 24 | $0.23 | $0.03 | ||
| Q2 24 | $-1.84 | $0.03 | ||
| Q1 24 | $0.05 | $0.02 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $375.2M | $479.7M |
| 总债务越低越好 | $570.5M | — |
| 股东权益账面价值 | $865.9M | $737.2M |
| 总资产 | $2.2B | $1.4B |
| 负债/权益比越低杠杆越低 | 0.66× | — |
8季度趋势，按日历期对齐
现金及短期投资MDPRVA
| Q4 25 | $375.2M | $479.7M | ||
| Q3 25 | $340.1M | $441.4M | ||
| Q2 25 | $224.7M | $390.1M | ||
| Q1 25 | $99.0M | $469.3M | ||
| Q4 24 | $229.9M | $491.1M | ||
| Q3 24 | $103.8M | $422.0M | ||
| Q2 24 | $19.4M | $387.4M | ||
| Q1 24 | $8.0M | $351.1M |
总债务MDPRVA
| Q4 25 | $570.5M | — | ||
| Q3 25 | $577.2M | — | ||
| Q2 25 | $583.9M | — | ||
| Q1 25 | $590.5M | — | ||
| Q4 24 | $597.1M | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
股东权益MDPRVA
| Q4 25 | $865.9M | $737.2M | ||
| Q3 25 | $890.7M | $709.1M | ||
| Q2 25 | $833.8M | $682.9M | ||
| Q1 25 | $789.2M | $659.4M | ||
| Q4 24 | $764.9M | $635.2M | ||
| Q3 24 | $732.5M | $614.9M | ||
| Q2 24 | $706.5M | $595.4M | ||
| Q1 24 | $856.2M | $576.8M |
总资产MDPRVA
| Q4 25 | $2.2B | $1.4B | ||
| Q3 25 | $2.2B | $1.4B | ||
| Q2 25 | $2.1B | $1.3B | ||
| Q1 25 | $2.0B | $1.2B | ||
| Q4 24 | $2.2B | $1.1B | ||
| Q3 24 | $2.1B | $1.1B | ||
| Q2 24 | $2.0B | $1.1B | ||
| Q1 24 | $2.2B | $1.0B |
负债/权益比MDPRVA
| Q4 25 | 0.66× | — | ||
| Q3 25 | 0.65× | — | ||
| Q2 25 | 0.70× | — | ||
| Q1 25 | 0.75× | — | ||
| Q4 24 | 0.78× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $114.1M | $127.5M |
| 自由现金流经营现金流 - 资本支出 | — | — |
| 自由现金流率自由现金流/营收 | — | — |
| 资本支出强度资本支出/营收 | — | — |
| 现金转化率经营现金流/净利润 | 3.39× | 13.93× |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流MDPRVA
| Q4 25 | $114.1M | $127.5M | ||
| Q3 25 | $137.3M | $52.0M | ||
| Q2 25 | $137.2M | $8.0M | ||
| Q1 25 | $-117.5M | $-24.1M | ||
| Q4 24 | $133.0M | $74.8M | ||
| Q3 24 | $91.8M | $33.2M | ||
| Q2 24 | $107.0M | $34.5M | ||
| Q1 24 | $-125.2M | $-33.1M |
现金转化率MDPRVA
| Q4 25 | 3.39× | 13.93× | ||
| Q3 25 | 1.91× | 7.58× | ||
| Q2 25 | 3.49× | 2.97× | ||
| Q1 25 | -5.66× | -5.70× | ||
| Q4 24 | 4.36× | 17.00× | ||
| Q3 24 | 4.72× | 9.38× | ||
| Q2 24 | — | 9.94× | ||
| Q1 24 | -31.03× | -11.10× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
MD
| Health Care Patient Service | $421.6M | 85% |
| Hospitals Contracts | $70.0M | 14% |
| Other | $2.2M | 0% |
PRVA
| FFS Patient Care | $364.4M | 67% |
| Capitated Revenue | $71.4M | 13% |
| Shared Savings | $46.9M | 9% |
| FFS Administrative Services | $36.0M | 7% |
| Care Management Fee PMPM | $20.0M | 4% |
| Other Revenue | $2.5M | 0% |
